NCT04802759 2026-03-16A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerHoffmann-La RochePhase 1/2 Recruiting316 enrolled
NCT05573555 2026-03-09TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)PfizerPhase 1/2 Active not recruiting20 enrolled
NCT01872260 2026-01-30Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerNovartisPhase 1/2 Active not recruiting255 enrolled
NCT07002177 2026-01-07A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BCForward Pharmaceuticals Co., Ltd.Phase 1/2 Recruiting196 enrolled
NCT06726148 2026-01-06Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid TumorsNovartisPhase 1/2 Recruiting280 enrolled
NCT05867251 2025-11-19Study of AVZO-021 in Patients With Advanced Solid TumorsAvenzo Therapeutics, Inc.Phase 1/2 Recruiting430 enrolled
NCT01543698 2024-03-13A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid TumorsPfizerPhase 1/2 Completed189 enrolled 44 charts